{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10624602",
  "DateCompleted": {
    "Year": "2000",
    "Month": "02",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0300-8126",
      "JournalIssue": {
        "Volume": "27",
        "Issue": "6",
        "PubDate": {
          "Year": "1999",
          "Season": "Nov-Dec"
        }
      },
      "Title": "Infection",
      "ISOAbbreviation": "Infection"
    },
    "ArticleTitle": "Important aspects of cost-effectiveness analysis in febrile neutropenia.",
    "Pagination": {
      "StartPage": "372",
      "EndPage": "375",
      "MedlinePgn": "372-5"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Karthaus",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Boehme",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ganser",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Juergens",
        "ForeName": "H",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Comment",
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Infection",
    "NlmUniqueID": "0365307",
    "ISSNLinking": "0300-8126"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Infection. 1999 Jan-Feb;27(1):23-7",
      "PMID": "10027102"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "economics",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cost-Benefit Analysis"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    }
  ]
}